Gland Pharma Ltd News

Gland Pharma jumps 9% to over 2-month high on strong Q3FY26 results

The share price rose as much as 9.32 per cent to ₹1,847.10, the highest level since November 14, 2025 on the National Stock Exchange (NSE)

Gland Pharma rises 5%, hits 1-month high on USFDA nod to eye-allergy drug

Gland Pharma jumped 4.80 per cent to ₹1,790.40, the highest level since December 3, 2025, on the National Stock Exchange.

Stocks to Watch today, Jan 8: Cipla, Tata Steel, Meesho, Shriram Fin, MCX

Stocks to Watch today, January 8, 2026: From Tata Steel to Cipla, here is a list of stocks that will be on investors' radar

Stocks to Watch today, Nov 4: Bharti Airtel, Titan, Hero MotoCorp, Cipla

Stocks to Watch today, November 4, 2025: From Bharti Airtel, Hero MotoCorp, Titan Company, and Power Grid, here is a list of stocks that will be in focus today

Gland Pharma Q2 results: Profit rises 12% on recovery at Europe's Cenexi

The consolidated net profit rose to 1.84 billion rupees (nearly $21 million) for the quarter ended September 30 from 1.64 billion rupees a year earlier

Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's

Jefferies is optimistic on India's CRDMO sector, given its evolution from quasi-chemical firms into strategic partners for innovators; check more details